Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center studyReport as inadecuate




Outcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study - Download this document for free, or read online. Document in PDF available to download.

BMC Cardiovascular Disorders

, 15:44

Cardiovascular surgery

Abstract

BackgroundAdvances in endovascular technology led to an alternative treatment option for TASC II D TransAtlantic Inter-Society Consensus II class D lesions. This study was aimed to evaluate the outcomes of endovascular treatment for TASC II D femoropopliteal lesions.

MethodsEndovascular intervention with bare nitinol stent implantation was performed on 58 limbs 53 patients with TASC II D femoropopliteal lesions from January 2011 to March 2013. Kaplan-Meier curves of primary patency, assisted patency and second patency were performed. Predictive factors of re-stenosis-occlusion were evaluated by univariate methods.

ResultsTotal 53 patients with mean age of 74.2 ± 8.2 range, 58.0–91.0 years and mean lesion length of 314.8 ± 64.3 mm 188.2–400.4 mm were enrolled. The mean follow-up time was 12.2 ± 6.1 months 5–38 months. Revascularization was successfully on 95 % lesions by bare nitinol stent implantation. Primary patency rates at 1, 2 and 3 years were 63 %, 12 % and 12 %, respectively. Assisted primary patency rates at 1, 2 and 3 years were 77 %, 31 % and 31 %, respectively. Secondary patency rates at 1, 2 and 3 years were 96 %, 63 % and 63 %. During one-year follow-up, no major amputation was occurred. Univariate analysis revealed that number of run-off vessels was a potential predictor of re-stenosis-occlusion.

ConclusionEndovascular treatment of TASC II D femoropopliteal artery occlusion has a high technical success rate with acceptable one-year patency rate. The long-term outcomes are poor, but endovascular intervention could be a good alternative for patients unsuitable for surgical bypass.

KeywordsPeripheral artery disease TASC II D lesions Endovascular treatment Patency rate Risk factor  Download fulltext PDF



Author: Xiangjiang Guo - Guanhua Xue - Xiaozhong Huang - Hui Xie - Wei Liang - Jiwei Zhang - Feng Lin - Tianping Yao

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents